des brevets
`
`Europaisches
`Patentamt
`European
`Patent Office
`Office européen
`
`(11)
`
`EP 2977 378 A1
`
`(12)
`
`EUROPEAN PATENT APPLICATION
`
`(43) Date of publication:
`27.01.2016 Bulletin 2016/04
`
`(21) Application number: 15177484.1
`
`(51)
`
`Int Cl.:
`CO7F 7/08 (2096.01)
`HO1L 511/50 (2996.91)
`
`CO9K 11/00 (2006.07)
`HO5B 33/14 (2006.01)
`
`(22) Dateoffiling: 20.07.2015
`
`
`(84) Designated Contracting States:
`AL AT BE BG CH CY CZ DE DK EE ES FI FR GB
`GR HR HU IE ISITLILT LU LV MC MK MT NL NO
`PL PT RO RS SE SISK SMTR
`
`Designated Extension States:
`BA ME
`
`Designated Validation States:
`MA
`
`(30) Priority: 23.07.2014 KR 20140093540
`
`(71) Applicants:
`¢ Samsung Electronics Co., Ltd
`Gyeonggi-do 443-742 (KR)
`¢ Samsung SDI Co., Ltd.
`Yongin-si, Gyeonggi-do (KR)
`
`(72)
`
`Inventors:
`
`.
`
`*
`
`.
`
`.
`
`SON, Jhunmo
`443-803 Gyeonggi-do (KR)
`KIM, Sangmo
`443-803 Gyeonggi-do (KR)
`KIM, Hyunjung
`443-803 Gyeonggi-do (KR)
`JEON, Soonok
`443-803 Gyeonggi-do (KR)
`CHUNG, Yeonsook
`443-803 Gyeonggi-do (KR)
`HUH, Dalho
`443-803 Gyeonggi-do (KR)
`
`Representative: Zijlstra, Robert Wiebo Johan
`Elkington and Fife LLP
`Prospect House
`8 Pembroke Road
`
`Sevenoaks, Kent TN13 1XR (GB)
`
`JUNG, Yongsik
`443-803 Gyeonggi-do (KR)
`
`
`(54)
`
`CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING
`THE SAME
`
`(57)
`Claimed are condensed cyclic compound of Formulae 1A to 1D and their use in organic electroluminescent
`light-emitting devices (OLED).
`
`Formula 1A
`
`Formula 1B
`
`(Riadaz
`
`(Ridarn
`
`(Rada
`
`AN
`—{Ry2)
`Xy
`\
`AiArs (Riadaz
`=
`f
`XX .(Ry3)a3
`
`EP2977378A1
`

`ty
`|
`N
`
`Xe
`X
`Der
`ic
`%
`[
`4
`Raadat
`oA it
`4 ST vy
`F
`\
`A 3
`Ar
`(Rizdaz
`
`(Ris)as
`
`I
`tN
`
`Xgom
`
`/
`xy
`v
`Xex7
`
`Xy
`>
`X>
`/
`Xs
`
`(Radarpry _—
`/
`Ar
`(Raz)a2
`
`™(Raadas
`
`
`
`Printed by Jouve, 75001 PARIS (FR)
`
`

`

`EP 2 977 378 A1
`
`Description
`
`FIELD OF THE INVENTION
`
`[0001] The presentdisclosure relates to a condensed cyclic compound and an organic light-emitting device including
`the same.
`
`BACKGROUND OF THE INVENTION
`
`[0002] Organic light-emitting devices (OLEDs) are self-emission devices that have wide viewing angles, high contrast
`ratios, shortresponse times. OLEDsalso have excellent brightness, driving voltage, and response speed characteristics,
`and produce full-color images.
`[0003]Atypical organic light-emitting device includes an anode, a cathode, and an organic layer that is disposed
`between the anode and the cathode and includes an emission layer. A hole transport region may be disposed between
`the anode and the emission layer, and an electron transport region may be disposed between the emission layer and
`the cathode. Holes provided from the anode may move toward the emission layer through the hole transport region, and
`electrons provided from the cathode may move toward the emission layer through the electron transport region. Carriers,
`such as holes and electrons, are recombined in the emission layer to produce excitons. These excitons change from
`an excited state to a ground state, thereby generating light.
`[0004] Various types of organic light emitting devices are known. However, there still remains a need in OLEDs having
`low driving voltage, high efficiency, high brightness, and long lifespan.
`
`10
`
`15
`
`20
`
`25
`
`30
`
`35
`
`40
`
`45
`
`50
`
`5S
`
`SUMMARY OF THE INVENTION
`
`Provided are a novel condensed cyclic compound and an organic light-emitting device including the same.
`[0005]
`[0006] Additional aspects will be set forth in part in the description which follows and,
`in part, will be apparent from
`the description, or may be learned by practice of the presented exemplary embodiments.
`[0007] According to an aspect of an exemplary embodiment, a condensed cyclic compound is represented by Formulae
`1Ato 1D:
`
`Formula 1A
`
`Formula 1B
`
`(R42)
`
`tela
`
`ar
`(Ravan
`Re
`an? 2
`I‘ary
`
`|
`
`
`
`~(Ri3)
`
`13/a3
`
`x
`
`/ 8==
`xs
`\
`a
`
`ne
`Ly
`|
`
`//
`
`R
`(Ra4)a1
`Ar,
`“ bars (R42)a2
`\
`—_—
`Ars
`
`_
`
`(R13)a3
`
`Formula 1C
`
`Formula 1D
`
`

`

`EP 2 977 378 A1
`
`Rg
`" 1
`4
`
`ff
`
`De
`X7
`
`"s
`L,
`
`Xs——
`X
`*
`xy
`f
`pt
`ip=
`(
`Xe— i LAY
`Ars~ \
`Av
`(Ri2)a2
`
`7 (Riadat
`
`i
`
`(Ris)ax~
`
`~—
`
`~
`
`{Ria)a2
`
`x,~.
`“xX,
`|
`Xs
`
`—
`
`Ary
`
`(Radar
`
`6 Xs
`(Ri3)a3 Ats~—oh
`ar!
`2
`
`wherein in Formulae 1A to 1 D,
`Xz is Nor C(R,),
`Xq is N or C(Ro),
`X3 is N or C(R3),
`Xq is N or C(Ra),
`Xs is N or C(Rs),
`Xz, is N or C(Rg),
`X; is N or C(R;), and
`Xg is N or C(Rg);
`L, is each independently selected from a substituted or unsubstituted C3-C,, cycloalkylene group, a substituted or
`unsubstituted C,-C,, heterocycloalkylene group, a substituted or unsubstituted C3-C49 cycloalkenylene group, a
`substituted or unsubstituted C4-C4 9 heterocycloalkenylene group, a substituted or unsubstituted C,g-Cgy arylene
`group, a substituted or unsubstituted C,-Cgg heteroarylene group, a substituted or unsubstituted divalent non-
`aromatic condensed polycyclic group, and a substituted or unsubstituted divalent non-aromatic condensed heter-
`opolycyclic group;
`Ar, to Arg are each independently a group derived from a Cg-Cg non-condensed carbocyclic group or a C,-Cz non-
`condensed heterocyclic group,
`R, to Rg and Ry, to R,3 are each independently selected from a hydrogen, a deuterium, -F, -Cl, -Br, -l, a hydroxyl
`group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a
`carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt
`thereof, a substituted or unsubstituted C,-Cg, alkyl group, a substituted or unsubstituted C,-Cgp alkenyl group, a
`substituted or unsubstituted C2-Cg, alkynyl group, a substituted or unsubstituted C,-Cg,, alkoxy group, a substituted
`or unsubstituted C3-C 4, cycloalkyl group, a substituted or unsubstituted C,-C, 9) heterocycloalkyl group, a substituted
`or unsubstituted C5-C4) cycloalkenyl group, a substituted or unsubstituted C,-C,) heterocycloalkenyl group, a sub-
`stituted or unsubstituted Cg-Cgy aryl group, a substituted or unsubstituted Cg-Cgy aryloxy group, a substituted or
`unsubstituted Cg-Cgp arylthio group, a substituted or unsubstituted C,-Cg, heteroaryl group, a substituted or unsub-
`stituted a monovalent non-aromatic condensed polycyclic group, a substituted or unsubstituted monovalent non-
`aromatic condensed heteropolycyclic group, and -N(Q,)(Qo);
`a1 to a3 are each independently an integer selected from 1, 2, 3, 4, 5, and 6, provided that when a1 is 2 or more,
`two or more groups R,, are identical to or different from each, when a2 is 2 or more, two or more groups Ry» are
`identical to or different from each other, and whena3 is 2 or more, two or more groups R43 are identical to or different
`from each other;
`wherein in each of Formulae 1A to 1D, groups *-Ar,-(R44)
`other;
`at least one substituent of the substituted C3-C,, cycloalkylene group, the substituted C,-C,, heterocycloalkylene
`group, the substituted C5-C49 cycloalkenylene group, the substituted C;-C,, heterocycloalkenylene group, the sub-
`stituted Cs-Cgp arylene group, the substituted C,-Cg, heteroarylene group, the substituted divalent non-aromatic
`condensedpolycyclic group, the substituted divalent non-aromatic condensed heteropolycyclic group, the substituted
`C,-Cgy alkyl group, the substituted C.-C,, alkenyl group, the substituted C5-Cgg alkynyl group, the substituted C,-Cgp
`alkoxy group, the substituted C3-C,, cycloalkyl group, the substituted C,-C,, heterocycloalkyl group, the substituted
`
`at -Alo-(Ry2)a2 and *-Ar3-(R13)43 are not identical to each
`
`10
`
`15
`
`20
`
`25
`
`30
`
`35
`
`40
`
`45
`
`50
`
`5S
`
`

`

`EP 2 977 378 A1
`
`C.3-C49 cycloalkenyl group, the substituted C,-C,, heterocycloalkenyl group, the substituted Cg-Cg,y aryl group, the
`substituted C,-Cg, aryloxy group, the substituted Cg-Cg,g arylthio group, the substituted C,-Cg, heteroaryl group,
`the substituted monovalent non-aromatic condensed polycyclic group, and the substituted monovalent non-aromatic
`condensed heteropolycyclic group may be selected from
`a deuterium, -F, -Cl, -Br, -!, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a
`hydrazine group, a hydrazone group, a carboxylic acid graup or a salt thereof, a sulfonic acid group or a salt thereof,
`a phosphoric acid group or a salt thereof, a C,-Cgp alkyl group, a C5-Cgg alkenyl group, a Co-Cgp alkynyl group, and
`a C4-Cgp alkoxy group;
`a Co-Cegp alkyl group, a C2-Cgo alkenyl group, a Co-Cgp alkynyl group, and a C,-Cg, alkoxy group, each substituted
`with at least one selected from deuterium, -F, -Cl, -Br, -], a hydroxyl group, a cyano group, a nitro group, an amino
`group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic
`acid group or a salt thereof, a phosphoric acid group or a salt thereof, a C3-C4, cycloalkyl group, a C,-C49 hetero-
`cycloalkyl group, a C3-C,, cycloalkenyl group, a C,-C,, heterocycloalkenyl group, a Cg-Cgy aryl group, a Cg-Cey
`aryloxy group, a Cg-Ce, arylthio group, a C,-Cg, heteroaryl group, a monovalent non-aramatic condensedpolycyclic
`group, a monovalent non-aromatic condensed heteropolycyclic group, and -N(Q,4)(Q,9);
`aC,-C,, cycloalkyl group, aC ,-C,, heterocycloalkyl group, a C3-C,, cycloalkenyl group, aC,-C,, heterocycloalkeny|
`group, a Cg-Cgg aryl group, a Cg-Cg, aryloxy group, a Cg-Cgy arylthio group, aC ,-Ce, heteroaryl group, a monovalent
`non-aromatic condensed polycyclic group, and a monovalent non-aromatic condensed heteropolycyclic group;
`aC,-C,, cycloalkyl group, a C,-C,, heterocycloalkyl group, a C3-C,, cycloalkenyl group, aC ,-C,, heterocycloalkeny|
`group, a Cg-Cgg aryl group, a Cg-Cgg aryloxy group, a Cg-Cgy arylthio group, aC ,-Cgq heteroaryl group, a monovalent
`non-aromatic condensed polycyclic group, and a monovalent non-aromatic condensed heteropolycyclic group, each
`substituted with at least one selected from a deuterium, -F, -Cl, -Br, -1, a hydroxyl group, a cyano group, a nitro
`group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt
`thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a C,-Cgy alkyl group, a
`Co-Cegg alkenyl group, a Co-Cgy alkynyl group, a Co-Cgy alkoxy group, a C3-C4) cycloalkyl group, a C,-C,, hetero-
`cycloalkyl group, a C3-C,, cycloalkenyl group, a C,-C,, heterocycloalkenyl group, a Cg-Cgy aryl group, a Cg-Ceg
`aryloxy group, a Cg-Cgg arylthio group, a Cy-Ce, heteroaryl group, a monovalent non-aromatic condensedpolycyclic
`group, a monovalent non-aromatic condensed heteropolycyclic group, and -N(Q54)(Qz9); and
`-N(Q34)(Q39);
`wherein Qy, Q5, Qy4, Qy2, Qg1, Qo2, Q3, and Qgy are each independently selected fram
`a hydrogen, a C4-Cgg alkyl group, a Co-Ceg alkenyl group, a Co-Cgg alkynyl group, a C,-C¢gp alkoxy group, a C3-C49
`cycloalkyl group, a C,-C4, heterocycloalkyl group, a C3-C 4, cycloalkeny! group, a C4-C4, heterocycloalkenyl group,
`a Ceg-Cgg aryl group, a C4-Cgg heteroaryl group, a monovalent non-aromatic condensed polycyclic group, and a
`monovalent non-aromatic condensed heteropolycyclic group; and
`aC,-C,, cycloalkyl group, a C,-C,, heterocycloalkyl group, a C3-C,, cycloalkenyl group, aC,-C,, heterocycloalkeny|
`group, a Cg-Cgp aryl group, a C,-Cg, heteroaryl group, a monovalent non-aromatic condensed polycyclic group,
`and a monovalent non-aromatic condensed heteropolycyclic group, each substituted with at least one selected from
`a deuterium, -F, -Cl, -Br, -i, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a
`hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group ora salt thereof,
`a phosphoric acid group or a salt thereof, a C,-Cg, alky! group, a Cy-Cg,q alkoxy group, a C3-C,, cycloalkyl group,
`a C,-Cyg heterocycloalkyl group, a C3-C4,9 cycloalkenyl group, a C,-C,, heterocycloalkenyl group, a Cg-Cgp aryl
`group, a C4-Cgy heteroaryl group, a monovalent non-aromatic condensed polycyclic group, and a monovalent non-
`aromatic condensed heteropolycyclic group.
`
`[0008] Another aspect provides an organic light-emitting device including:
`
`a first electrode;
`a second electrode; and
`an organic layer disposed between the first electrode and the second electrode, wherein the organic layer includes
`an emission layer, and further includes at least one condensed cyclic compound.
`
`BRIEF DESCRIPTION OF THE DRAWINGS
`
`[0009] These and/or other aspects will become apparent and more readily appreciated from the following description
`of the exemplary embodiments, taken in conjunction with FIG. 1 which is a schematic view of an organic light-emitting
`device according to an embodiment.
`
`10
`
`15
`
`20
`
`25
`
`30
`
`35
`
`40
`
`45
`
`50
`
`5S
`
`

`

`DETAILED DESCRIPTION OF THE EMBODIMENTS
`
`EP 2 977 378 A1
`
`15
`
`20
`
`25
`
`[0010] Reference will now be made in detail to exemplary embodiments, examples of which areillustrated in the
`accompanying drawings, wherein like reference numerals refer to like elements throughout. In this regard, the present
`exemplary embodiments may havedifferent forms and should not be construed as being limited to the descriptions set
`forth herein. Accordingly, the exemplary embodiments are merely described below, by referring to the figures, ta explain
`aspects. As used herein, the term "and/or" includes any and all combinations of one or more of the associated listed
`items. Expressions such as “at least one of," when preceding a list of elements, modify the entire list of elements and
`do not modify the individual elements ofthelist.
`10
`[0011]=It will be understood that when an element is referred to as being "on" another element, it can be directly in
`contact with the other element or intervening elements may be present therebetween. In contrast, when an element is
`referred to as being "directly on" another element, there are no intervening elements present.
`[0012]
`It will be understood that, although the terms first, second, third etc. may be used herein to describe various
`elements, components, regions, layers, and/or sections, these elements, components, regions, layers, and/or sections
`should not be limited by these terms. These terms are only usedto distinguish one element, component, region, layer,
`or section from another element, component, region, layer, or section. Thus, a first element, component, region, layer,
`or section discussed below could be termed a second element, component, region, layer, or section without departing
`from the teachings of the present embodiments.
`[0013] The terminology used herein is for the purpose of describing particular embodiments only and is not intended
`to be limiting. As used herein, the singular forms "a," "an," and "the" are intended to include the plural forms as well,
`unlessthe context clearly indicates otherwise.
`[0014]
`It will be further understood that the terms “comprises” and/or “comprising,” or "includes" and/or “including”
`when usedin this specification, specify the presence of stated features, regions, integers, steps, operations, elements,
`and/or components, but do not preclude the presenceor addition of one or more other features, regions, integers, steps,
`operations, elements, components, and/or groups thereof.
`"upper" and the like, may be used herein
`"above,"
`[0015]
`Spatially relative terms, such as "beneath," "below," "lower,"
`for ease of description to describe one element or feature’s relationship to another element(s) or feature(s) as illustrated
`in the figures. It will be understood that the spatially relative terms are intended to encompassdifferent orientations of
`the device in use or operation in addition to the orientation depicted in the figures. For example, if the device in the
`figures is turned over, elements described as "below" or “beneath” other elements or features would then be oriented
`"above" the other elements or features. Thus, the exemplary term "below" can encompassboth an orientation of above
`and below. The device may be otherwise oriented (rotated 90 degreesor at other orientations) and the spatially relative
`descriptors used herein interpreted accordingly.
`[0016]
`"About" or "approximately" as used herein is inclusive of the stated value and means within an acceptable
`range of deviation for the particular value as determined by one ofordinary skill in the art, considering the measurement
`in question and the error associated with measurement of the particular quantity (i.e., the limitations of the measurement
`system). For example, "about" can mean within one or more standard deviations, or within + 30%, 20%, 10%, 5% of
`the stated value.
`
`30
`
`35
`
`[0017] Unless otherwise defined, all terms (including technical and scientific terms) used herein have the same meaning
`as commonly understood by one of ordinary skill in the art to which this invention belongs.It will be further understood
`that terms, such as those defined in commonly used dictionaries, should be interpreted as having a meaning thatis
`consistent with their meaning in the context of the relevant art and the present disclosure, and will not be interpreted in
`an idealized or overly formal sense unless expressly so defined herein.
`[0018] Exemplary embodiments are described herein with reference to cross section illustrations that are schematic
`illustrations of idealized embodiments. As such, variations from the shapesofthe illustrations as a result, for example,
`of manufacturing techniques and/or tolerances, are to be expected. Thus, embodiments described herein should not be
`construed aslimited to the particular shapes of regions asillustrated herein but are to include deviations in shapes that
`result, for example, from manufacturing. For example, a region illustrated or described asflat may, typically, have rough
`and/or nonlinear features. Moreover, sharp angles that are illustrated may be rounded. Thus, the regions illustrated in
`the figures are schematic in nature and their shapes are not intendedto illustrate the precise shape of a region and are
`not intended to limit the scope of the present claims.
`[0019] An aspect provides a condensed cyclic compound represented by Formulae 1A to 1 D below:
`
`40
`
`45
`
`50
`
`5S
`
`

`

`EP 2 977 378 A1
`
`Formula 1A
`
`Formula 1B
`
`xy
`
`\
`
`Ar,
`
`—
`Ar.
`xx AS
`(Ri3)a3
`
`Formula 1C
`
`Formula 1D
`
`Ro
`
`|1
`
`R
`
`I"
`Ly
`|
`Pes
`x
`x pt_
`Xe—
`neh LAK 11?a1
`si
`Ar” \
`” 3
`Ar
`(Ri3)a3
`Vv
`(Ri2)a2
`
`(Ri1)
`
`x
`Po
`*X,
`X7
`a /
`5
`(Ris)as~qr,—_ fs
`/
`Aro
`
`Ary
`
`(Rai)at
`
`N
`
`(Ri2)a2
`
`In Formulae 1A to 1 D,
`X, may be N or C(R,),
`Xz may be N or C(R>),
`X3 may be N or C(R3),
`Xq4 may be N or C(Ry),
`Xs may be N or C(Rs),
`Xg may be N or C(Rg),
`Xz may be N or C(R7), and
`Xg may be N or C(Rg).
`
`ON
`
`[0020]
`
`In some embodiments, in Formulae 1A to 1 D,
`
`X4 may be C(R;),
`X_ may be C({Ro),
`X3 may be C(R3),
`Xq4 may be C(Ry),
`Xs may be C(Rs),
`Xg may be C({Rg),
`X7 may be C(R7), and
`Xg may be C(Rg).
`In some embodiments,
`one, two, or three elements selected from Xz to Xg in Formula 1A may be N;
`one, two, or three elements selected from X4 and X3 to Xg in Formula 1 B maybe N;
`one, two, or three elements selected from X4, Xz and X, to Xg in Formula 1C may be N; and
`
` (Raadat
`
`\ars (Ri2)az
`
`— R
`
`10
`
`15
`
`20
`
`25
`
`30
`
`35
`
`40
`
`45
`
`50
`
`5S
`
`

`

`EP 2 977 378 A1
`
`one, two, or three elements selected from X, to X3 and Xz to Xg in Formula 1 D may be N,
`but they are notlimited thereto.
`
`[0021]
`
`For example, in Formulae 1A to 1D,
`
`X, is N, Xz is C(R,), X3 is C(R3), X4 is C(Ry), Xs is C(Rs), Xg is C(Rg), X7 is C(Rz), and Xz is C(Rg);
`X, is C(R,), Xo is N, X3 is C(R3), X4 is C(R4), Xs is C(Rzg), Xg is C(Rg), X7 is C(Rz), and Xg is C(Rg);
`Xz is C(R4), Xq is C(Ra), X3 is N, Xq is C(Ry), Xs is C(Rs), Xg is C(Rg), X7 is C(Rz), and Xg is C(Rg);
`Xz is C(R4y), Xp is C(R9), X3 is C(R3), X4 is N, Xs is C(Rs), Xg is C(Rg), X7 is C(Rz), and Xz is C(Rg);
`X_ is C(R4), Xq is C(Ro), X3 is C(R3), X4 is C(Ry), Xs is N, Xg is C(Rg), X7 is C(R7), and Xz is C(Rg);
`Xz is C(R4), Xo is CCR), X3 is C(R3), X4 is C(R4), Xs is C(Rg), Xg is N, X7 is C(R7), and Xg is C(Rg);
`Xz is C(R4), Xq is CCR), X3 is C(R3), X4 is C(Ry), Xs is C(Re), Xg is C(Rg), X7 is N, and Xg is C(Rg);
`Xz
`is C(R4), Xo is C(Ro), X3 is C(R3), X4 is C(Ry), Xs is C(Rs), Xg is C(Rg), X7 is C(Rz), and Xg is N;
`X, is C(Ry), Xo is C(Rz), X3 is C(R3), X4 is C(Ry), Xs is C(Re), Xg iS N, X7 is C(Rz), and Xg is N;
`Xz
`is C(Ry), X2 is C(R2), X3 is C(R3), X4 is C(Ry), Xs is N, Xg is C(Rg), X7 is N, and Xg is C(Rg);
`Xz is C(R4), Xq is N, X3 is C(Rg), X4 is C(Ry), Xs is C(Rs), Xg is C(Rg), X7 is N, and Xg is C(Rg);
`X, is C(R4), Xz is C(Ro), X3 is C(R3), X4 is N, X, is N, Xg is C(Rg), X7 is C(Rz), and Xg is C(Rg); or
`X,
`is C(R,), Xp is C(R»), X3 is N, Xq is C(Ry), Xs is C(Rs), Xg is N, X7 is C(R7), and Xg is C(Rg), but they are not
`limited thereto.
`
`= =
`
`in Formulae 1A and 1 D may be each independently selected from a substituted or unsubstituted C3-C49 cy-
`L,
`cloalkylene group, a substituted or unsubstituted C,-C,, heterocycloalkylene group, a substituted or unsubstituted
`C3-C49 cycloalkenylene group, a substituted or unsubstituted C,-C4) heterocycloalkenylene group, a substituted or
`unsubstituted Cg-Cg, arylene group, a substituted or unsubstituted C,-Cgy heteroarylene group, a substituted or
`unsubstituted divalent non-aromatic condensed polycyclic group, and a substituted or unsubstituted divalent non-
`aromatic condensed heteropolycyclic group.
`
`For example, L, in Formulae 1A to 1 D may be each independently selected from a substituted or unsubstituted
`[0022]
`C_-Ca9 arylene group, a substituted or unsubstituted C ,-C, heteroarylene group, a substituted or unsubstituted divalent
`non-aromatic condensed polycyclic group, and a substituted or unsubstituted divalent non-aromatic condensed heter-
`opolycyclic group.
`[0023]
`In some embodiments, L,
`
`in Formulae 1A to 1 D may be selected from
`
`a phenylene group, a naphthylene group, a fluorenylene group, a phenanthrenylene group, an anthracenylene
`group, a triphenylenylene group, a pyrenylene group, a chrysenylene group, a pyridinylene group, a pyrazinylene
`group, a pyrimidinylene group, a pyridazinylene group, and a triazinylene group; and
`a phenylene group, a naphthylene group, a fluorenylene group, a phenanthrenylene group, an anthracenylene
`group, a triphenylenylene group, a pyrenylene group, a chrysenylene group, a pyridinylene group, a pyrazinylene
`group, a pyrimidinylene group, a pyridazinylene group, and a triazinylene group, each substituted with at least one
`selected from a deuterium, -F, -Cl, -Br, -l, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino
`group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a
`salt thereof, a phosphoric acid group or a salt thereof, a C,-Cy alkyl group, a C,-C5, alkoxy group, a phenyl group,
`a naphthyl group, a fluorenyl group, a phenanthrenyl group, an anthracenyl group, a triphenylenyl group, a pyrenyl
`group, achrysenyl group, a pyridinyl group, a pyrazinyl group, a pyrimidinyl group, a pyridazinyl group, and a triazinyl
`group,
`but they are not limited thereto.
`
`[0024]
`
`In some embodiments, L,
`
`in Formulae 1A to 1 D may be selected from
`
`a phenylene group, a naphthylene group, a pyridinylene group, a pyrimidinylene group, and a triazinylene group; and
`a phenylene group, a naphthylene group, a pyridinylene group, a pyrimidinylene group, and a triazinylene group,
`each substituted with at least one selected from a deuterium, -F, -Cl, -Br, -l, a hydroxyl group, a cyano group, a nitro
`group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt
`thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a C,-C,, alkyl group, a
`C,-C49 alkoxy group, a phenyl group, and a naphthyl group.
`Ar, to Ars in Formulae 1A to 1 D may be each independently a group derived from a C.-Cg non-condensed carbocyclic
`group or a C4-C7 non-condensed heterocyclic group.
`
`[0025]
`
`In some embodiment, Ar, and Arg in Formulae 1A to 1 D may be each independently represented by one of
`
`10
`
`15
`
`20
`
`25
`
`30
`
`35
`
`40
`
`45
`
`50
`
`5S
`
`

`

`Formulae 2-1 to 2-40 below:
`
`EP 2 977 378 A1
`
`xe
`‘X13
`
`JagXs
`
`Formula 2-1
`
`xteLk
`
`Xis
`
`Formula 2-7
`
`*
`
`xe
`X43
`
`x
`
`X
`
`x / ye
`
`Xe
`
`Kh
`
`X2
`
`/
`
`*
`
`X42
`
`xa
`X2
`
`wy,
`
`X3
`
`*
`
`Formula 2-2
`
`Formula 2-3
`
`Formula 2-4
`
`Formula 2-5
`
`X42
`
`X12
`
`‘8
`Xt
`is
`X14
`ow v4 A om
`X
`*
`XQ
`Formula 2-8
`Formula 2-9
`
`*
`
`1
`
`Xi2
`
`Xi we
`xX i"
`7X2 A ka
`X43
`X43
`Formula 2-10
`Formula 2-11
`
`Xx
`xq <x,
`KOSy
`* x3
`
`X12
`
`oe
`xr
`¥r
`aoXs
`
`Xa
`
`ke
`
`Formula 2-13
`
`Formula 2-14
`
`2
`4X12-X49
`7X2~Xq3
`XK
`~ X3
`Xa4
`\
`Xa
`\
`FE Fo» RR >»
`oe
`x
`Roy
`Xs
`XygoM15
`Xq7A185
`Formula 2-15
`Formula 2-16
`Formula 2-17
`
`*
`
`xeye,
`
`Formula 2-6
`
`Formula 2-12
`
`X42~/
`Xa
`
`X13
`\1
`4
`Xie*2
`Formula2-18
`
`Z 12 Xa
`Xqo~
`WA i
`11
`x
`Kya
`
`*
`
`Pen, ZX
`147%
`—
`Xo~—X.
`S
`/* N ie A
`x7
`1
`X44
`\
`1
`\
`Pak of
`—Ky3
`XeXa
`oh
`
`Pa
`
`Formula 2-20
`
`Formula 2-21.
`
`Formula 2-22
`
`Formula 2-23
`
`Xe4
`Formula2-24
`
`71K
`Xa
`
`\2
`
`Xa*8
`Formula 2-19
`
`1
`
`x
`Xx
`Xi 4
`Xai 12
`I
`Xa
`X
`sx ao Xap
`Formula 2-26
`Formula 2-27
`
`aN
`Xe
`i ye
`aKa
`Formula 2-28
`
`xx
`i
`"°
`No X14
`ZN
`Xis
`Formula 2-29
`
`*
`
`eonx7
`Formula 2-30
`
`N
`
`X>
`
`X43
`Formula 2-31
`
`x
`x ‘sx,
`N
`X12
`ae xT
`Formula 2-32
`
`X
`x7 on
`|
`ZN. aX
`x7
`Formula 2-33
`
`*
`
`2X43
`\
`Xieot
`Formula 2-34
`
`KON,
`
`14
`
`Xx
`7X3
`“
`x
`N
`Y
`RON _
`Xia Xe
`Formula 2-35
`
`4
`
`Xy2~
`71K
`1"
`\
`N _/Ma
`Sy€s
`Formula 2-37
`
`—
`
`x
`Xi
`Prk
`7S
`x7
`ut
`\
`‘
`”
`u
`N
`Ar
`xeoX Ngo
`Formula 2-38
`Formula 2-39
`
`RON
`
`xX
`P*rXs
`x7
`.
`hi
`Ms
`aa SxXs
`Formula 2-40
`
`X12~
`
`x4
`
`7
`
`\2
`“
`/
`N
`#7 ONY
`Xi 8
`Formula 2-36
`
`*
`
`*
`
`wherein in Formulae 2-1 to 2-40,
`
`X41 is O, S, N(Z44) or C(Z44a)(Z4 4p), X42 is O, S, N(Z42) or C(Z42q)(Z 42H), X13 is O, S, N(Z43) or C(Z43q)(Z4 3p), X14
`is O, S, N(Z44) or C(Z44q)(Z44p), X45 is O, S, N(Z45) of C(Z45a)(Zi5p), X46 is O, S, N(Zy9) or C(Z4¢q)(Z 16):
`X, is N or C(Z,), Xq is N or C(Z3), X3 is N or C(Z3), Xq is N or C(Z,), X5 is N or C(Zs5), and Xg is N or C(Z¢);
`241 10 216, 2444 10 Zig4, 24 4p 10 Zigp, and Z, to Z, are each independently a hydrogen, or a binding site to each of
`
`10
`
`15
`
`20
`
`25
`
`30
`
`35
`
`40
`
`45
`
`50
`
`5S
`
`

`

`EP 2 977 378 A1
`
`R41, Ry, and R,3 in Formulae 1A to 1 D; and
`*is a binding site to Si in Formulae 1A to 1 D.
`
`For example, Ar, to Ars in Formulae 1 A to 1 D may be each independently selected from groups represented
`[0026]
`by Formulae 2-5 to 2-7, 2-15, 2-22, 2-23, and 2-24, but they are notlimited thereto.
`[0027]
`!n some embodiments, Ar, to Ars in Formulae 1A to 1 D may be each independently a group derived from a
`compound selected from a benzene, a pyridine, a pyrazine, a pyrimidine, a pyridazine, a triazine, a furan, a thiophene,
`a pyrrole, an imidazole, a triazole, a cyclohexane, a tetrahydro-2H-pyran, a piperidine, a tetrahydro-2H-thiopyran, a
`(2Z,4Z,6Z)-oxepine, a (2Z,4Z2,6Z)-1H-azepine, and a (2Z,4Z,6Z)-thiepine.
`[0028] R,toRgandR,, to R,3 in Formulae 1A to 1D may be each independently selected from a hydrogen, adeuterium,
`-F, -Cl, -Br, -|, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group, a
`hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid
`group or a salt thereof, a substituted or unsubstituted C,-Cg, alkyl group, a substituted or unsubstituted C>-Cg, alkenyl
`group, a substituted or unsubstituted C5-Cg, alkynyl group, a substituted or unsubstituted C,-Cg, alkoxy group, a sub-
`stituted or unsubstituted C3-C,, cycloalkyl group, a substituted or unsubstituted C,-C,,) heterocycloalkyl group, a sub-
`stituted or unsubstituted C5-C,, cycloalkenyl group, a substituted or unsubstituted C,-C,, heterocycloalkenyl group, a
`substituted or unsubstituted Cg-Cgy aryl group, a substituted or unsubstituted Cg.-Cg, aryloxy group, a substituted or
`unsubstituted Cg-Cgy arylthio group, a substituted or unsubstituted C ,-C,, heteroaryl group, a substituted or unsubstituted
`a monovalent non-aromatic condensed polycyclic group, a substituted or unsubstituted monovalent non-aromatic con-
`densed heteropolycyclic group, and -N(Q,)(Qz).
`
`Q, and Q, maybe each independently selected from
`a hydrogen, a C,-Cgp alkyl group, a C2-Cgy alkenyl group, a C2-Cgg alkynyl group, a C;-Cgp alkoxy group, a C3-C4
`cycloalkyl group, a C,-C,, heterocycloalkyl group, a C3-C,, cycloalkeny! group, a C,-C,, heterocycloalkeny| group,
`a C.-Cgp aryl group, a C,-Cgy heteroaryl group, a monovalent non-aromatic condensed polycyclic group, and a
`monovalent non-aromatic condensed heteropolycyclic group; and
`aC,-C,, cycloalkyl group, aC,-C,, heterocycloalkyl group, a C3-C,, cycloalkenyl group, aC,-C,,) heterocycloalkeny|
`group, a Cg-Cegg aryl group, a C,-Cg, heteroaryl group, a monovalent non-aromatic condensed polycyclic group,
`and a monovalent non-aromatic condensed heteropolycyclic group, each substituted with at least one selected from
`a deuterium, -F, -Cl, -Br, -l, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a
`hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group ora salt thereof,
`a phosphoric acid group or a salt thereof, a C;-Cgp alkyl group, a C4-Cgg alkoxy group, a C3-C4, cycloalkyl group,
`a C,-Cy49 heterocycloalkyl group, a C3-C49 cycloalkenyl group, a Cy-Cj) heterocycloalkenyl group, a Cg-Cgp aryl
`group, a C4-Cgg heteroaryl group, a monovalent non-aromatic condensed polycyclic group, and a monovalent non-
`aromatic condensed heteropolycyclic group.
`
`[0029]
`
`Insome embodiments, R, to Rg and R,, to R;3 in Formulae 1A to 1D may be each independently selected from
`
`a hydrogen, a deuterium, -F, -Cl, -Br, -], a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino
`group, a hydrazine group, a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a
`salt thereof, a phosphoric acid group or a salt thereof, a C,-Cy, alkyl group, and a C,-Co, alkoxy group;
`a C,-Cy, alkyl group and a C,-Cyy alkoxy group, each substituted with at least one selected from a deuterium, -F,
`-Cl, -Br, -l, a hydroxyl group, a cyano group, a nitro group, an amino group, an amidino group, a hydrazine group,
`a hydrazone group, a carboxylic acid group or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric
`acid group or a salt thereof, a phenyl group, a pyridinyl group, a pyrimidinyl group, and a triazinyl group;
`a cyclopentyl group, a cyclohexy! group, a cyclopentenyl group, a cyclohexenyl group, a cycloheptenyl group, a
`piperidinyl group, a tetrahydro-2H-pyranyl group, a tetrahydro-2H-thiopyranyl group, a phenyl group, a fluorenyl
`group, a dibenzosilolyl group, a pyrrolyl group, an imidazolyl group, a pyrazolyl group, a pyridinyl group, a pyrazinyl
`group, a pyrimidinyl group, a pyridazinyl group, an isoindolyl group, an indolyl group, a furanyl group, a thiophenyl
`group, a thiazoly| group, an isothiazolyl group, an isoxazolyl group, an oxazolyl group, a triazolyl group, a tetrazalyl
`group, an oxadiazolyl group, a triazinyl group, a carbazolyl group, a dibenzofuranyl group, and a dibenzothiophenyl
`group;
`a cyclopentyl group, a cyclohexy! group, a cyclopentenyl group, a cyclohexenyl group, a cycloheptenyl group, a
`piperidinyl group, a tetrahydro-2H-pyranyl group, a tetrahydro-2H-thiopyranyl group, a phenyl group, a fluocrenyl
`group, a dibenzosilolyl group, a pyrrolyl group, an imidazolyl group, a pyrazolyl group, a pyridinyl group, a pyrazinyl
`group, a pyrimidinyl group, a pyridazinyl group, an isoindolyl group, an indolyl group, a furanyl group, a thiopheny|
`group, a thiazoly| group, an isothiazolyl group, an isoxazolyl group, an oxazolyl group, a triazolyl group, a tetrazolyl
`group, an oxadiazolyl group, a triazinyl group, a carbazolyl group, a dibenzofuranyl group, and a dibenzothiopheny|
`
`10
`
`15
`
`20
`
`25
`
`30
`
`35
`
`40
`
`45
`
`50
`
`5S
`
`

`

`EP 2 977 378 A1
`
`group, each substituted with at least one selected from a deuterium, -F, -Cl, -Br, -l, a hydroxyl group, a cyano group,
`a nitro group, an amino group, an amidino group, a hydrazine group, a hydrazone group, a carboxylic acid group
`or a salt thereof, a sulfonic acid group or a salt thereof, a phosphoric acid group or a salt thereof, a C4-Cy9 alkyl
`group, a C4-C>9 alkoxy group, a cyclopentyl group, a cyclohexyl group, a cyclopentenyl group, a cyclohexenyl group,
`a cycloheptenyl group, a piperidinyl group, a tetrahydro-2H-pyranyl group, a tetrahydro-2H-thiopyranyl group, a
`phenyl group, a fluorenyl group, a dibenzosilolyl group, a pyrrolyl group, an imidazolyl group, a pyrazoly! group, a
`pyridinyl group, a pyraziny! group, a pyrimidinyl group, a pyridazinyl group, an isoindolyl group, an indolyl group, a
`furanyl group, a thiopheny! group, a thiazolyl group, an isothiazolyl group, an isoxazolyl group, an oxazolyl group,
`a triazolyl group, a tetrazolyl group, an oxadiazolyl group, a triazinyl group, a carbazolyl group, a dibenzofuranyl
`group, a dibenzothiophenyl group, and -N(Q3,)(Q39); and
`-N(Q,)(Qz),
`wherein Qy, Qo, Q31, and Q35 are each independently selected from
`a hydrogen, a C,-Co5y alkyl group, a C,-C5, alkoxy group, a cyc

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.

We are unable to display this document.

PTO Denying Access

Refresh this Document
Go to the Docket